MAOYAN ENT (01896) rose more than 7% intraday during the trading session. As of press time, the stock was up 3.44% at HK$7.81, with a turnover of HK$121 million.

Recently, Citi issued a report initiating a 30-day positive catalyst watch on MAOYAN ENT, citing the upcoming release of the major animated film *Demon Slayer: Kimetsu no Yaiba* on November 14, for which MAOYAN serves as the distributor. The film has already demonstrated strong global box office performance, ranking fifth worldwide with over $677 million in revenue and becoming the top international film in North America. The announcement has generated significant buzz, evidenced by a record-breaking 400,000 "want-to-watch" clicks on MAOYAN's professional platform within a single day.

Citi expects *Demon Slayer* to become the highest-grossing Japanese animated film in China, projecting box office revenue of up to RMB 1 billion. The bank estimates a potential profit contribution ranging between RMB 108 million and RMB 200 million. Citi also anticipates that any outperformance in box office results could serve as a positive catalyst for MAOYAN as the largest ticketing platform. The bank maintains a "Buy" rating with a target price of HK$9.3, based on a 14x adjusted 2026 earnings multiple.